Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment.
about
Near IR heptamethine cyanine dye-mediated cancer imagingAdded Value of Assessing Adnexal Masses with Advanced MRI TechniquesDynamic Contrast-Enhanced CT in Patients with Pancreatic CancerContrast-Enhanced Ultrasound in the Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Controversy over the ASSLD GuidelineEvaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma.Three-dimensional reconstruction of neovasculature in solid tumors and basement membrane matrix using ex vivo X-ray microcomputed tomographyMagnetoliposomes: versatile innovative nanocolloids for use in biotechnology and biomedicine.In vivo imaging demonstrates a time-line for new vessel formation in islet transplantationFunctional and structural characteristics of tumor angiogenesis in lung cancers overexpressing different VEGF isoforms assessed by DCE- and SSCE-MRI.Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging.HiSStology: high spectral and spatial resolution magnetic resonance imaging detection of vasculature validated by histology and micro-computed tomographyContrast-enhanced dedicated breast CT: initial clinical experienceEstimation of radiation exposure of 128-slice 4D-perfusion CT for the assessment of tumor vascularity.Dedicated breast computed tomography: the optimal cross-sectional imaging solution?Transit delay and flow quantification in muscle with continuous arterial spin labeling perfusion-MRI.Gastric carcinoma: imaging diagnosis, staging and assessment of treatment response.CT perfusion of the liver: principles and applications in oncology.ROCKETSHIP: a flexible and modular software tool for the planning, processing and analysis of dynamic MRI studies.The use of tumour volumetrics to assess response to therapy in anticancer clinical trialsIn vivo magnetic resonance imaging of vascularization in islet transplantationDose-response relationship of ultrasound contrast agent in an in vivo murine melanoma modelSemi-quantitative contrast-enhanced MR analysis of indeterminate ovarian tumours: when to say malignancy?Alignment of sources and detectors on breast surface for noncontact diffuse correlation tomography of breast tumors.Clinical biomarkers of angiogenesis inhibition.Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?Assessment of blood flow in hepatocellular carcinoma: correlations of computed tomography perfusion imaging and circulating angiogenic factorsMorphological and functional MDCT: problem-solving tool and surrogate biomarker for hepatic disease clinical care and drug discovery in the era of personalized medicine.Perfusion computed tomography in colorectal cancer: protocols, clinical applications and emerging trends.In vivo small animal imaging: current status and future prospects.Imaging tumor vascularization for detection and diagnosis of breast cancer.Dual-energy computed tomography applications in uroradiology.Can increased tumoral vascularity be a quantitative predicting factor of lymph node metastasis in papillary thyroid microcarcinoma?Metastatic renal cell carcinoma imaging evaluation in the era of anti-angiogenic therapies.Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography.Improved accuracy of quantitative parameter estimates in dynamic contrast-enhanced CT study with low temporal resolution.Optimizing the size variation threshold for the CT evaluation of response in metastatic renal cell carcinoma treated with sunitinib.Feasibility study of CT perfusion imaging for prostate carcinoma.Focusing on delayed clearance for identifying small-sized metastatic lung tumors using synchrotron radiation angiography with a highly sensitive receiver.Correlation of contrast-enhanced ultrasound kinetics with prognostic factors in invasive breast cancer.Esophageal squamous cell carcinoma: assessing tumor angiogenesis using multi-slice CT perfusion imaging.
P2860
Q24616262-165C9F51-3C99-4B86-8567-D27C5EA65424Q26785606-4A971333-614A-475C-82C3-9128A7F5D221Q28069587-78F65678-944A-45D3-83E6-5DD17B196FCBQ30408973-AC6701F5-55B7-4972-AB78-84E30AA7BCB1Q30436716-4D578688-C205-46A8-A86F-B6ADC3AEEEABQ30588927-D7E88666-B625-4E82-8F1A-49AAC2EC66E7Q33405614-547BBD63-43BD-4C8C-A9E1-39B54FF73A1BQ33723356-BE01218E-3260-4195-88DB-78244BC852B2Q33809311-F52517DA-2B5B-476B-9CEE-0B042F28107CQ33813238-5652980A-ED7E-4B4E-903E-FD9B12242ECAQ33857065-6ECAC69F-8924-441C-8052-B50233C31AD9Q34073457-DBADBB2E-7EF0-483A-9677-310336C7635EQ34092033-22E4D67B-2B7C-4571-801E-B015AEB7F905Q34273318-6B6888BA-956B-4DB7-A34F-2861B7769103Q34483020-555E6DB7-8381-40EC-83BB-B668299B6DB7Q34652398-004FE5E9-F314-404E-BFE9-DB4E88E1A337Q34681040-B6E6D3C2-501D-4422-9F2E-400298B356C5Q35664458-FA7EF31A-0D61-4346-9700-A24FF8CE9956Q36081423-C2493576-BF5C-4BB5-9B89-40F4CA1474D1Q36168739-74BE018F-5744-476F-88E3-BF9F4195EEA8Q36295224-354F247F-FBF4-4BA8-93EE-5C0CED2D239CQ36550912-11069BA6-EEC0-40E9-8B7D-4F4787255216Q36710040-20FBAFFC-E284-40CC-AED1-08BE019C7A51Q37139413-BFE7239A-F471-4EDC-9488-6EDC23468795Q37205008-7C61DD7A-1028-403C-B326-6C3E2EA457DAQ37225055-BC40CA8C-B3BA-47D0-862F-9B48892C1727Q37356037-65F46B91-076E-4241-BD03-A84048316E69Q37550249-A95A2C84-F9D1-427A-A804-82DA9CDCBA7EQ37837837-65F7FB51-441F-48D5-9FCC-183E86EE82D4Q37953954-C0984636-8C16-46A2-B931-8244BA328100Q37954128-C6F45EF8-A850-4191-A80E-280778959F39Q38443234-E0DF03B4-917A-41A1-A1E0-94FFA1E7BCFAQ38837758-B1BAF73F-56BF-435A-A198-91B7CBEF4A53Q39647845-E7052453-E210-4728-A222-CA6E21C3FFE0Q40128427-EEB9AF10-28D9-473B-AAD4-9072E7B5A0A1Q43248494-3BB50BC6-A75B-4726-8FB7-F78322946598Q45370083-EDF423DC-237C-42C2-A345-A56E155F15A4Q53059784-06B2C518-1B0A-43F0-9B28-A8A4AF3471A3Q53103147-DF21ABB6-5887-4F39-BEF8-4837A378DD97Q53167550-1C75B174-3E22-4589-8AC2-F267099A740B
P2860
Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Tumor angiogenesis: pathophysi ...... nhanced MRI and CT assessment.
@ast
Tumor angiogenesis: pathophysi ...... nhanced MRI and CT assessment.
@en
type
label
Tumor angiogenesis: pathophysi ...... nhanced MRI and CT assessment.
@ast
Tumor angiogenesis: pathophysi ...... nhanced MRI and CT assessment.
@en
prefLabel
Tumor angiogenesis: pathophysi ...... nhanced MRI and CT assessment.
@ast
Tumor angiogenesis: pathophysi ...... nhanced MRI and CT assessment.
@en
P2093
P1433
P1476
Tumor angiogenesis: pathophysi ...... nhanced MRI and CT assessment.
@en
P2093
Fournier L
Guinebretière JM
P2860
P304
P356
10.1007/S00261-005-0386-5
P577
2006-03-01T00:00:00Z